Related Experiment Video
Updated: Dec 30, 2025

Cytological Analysis of Spermatogenesis: Live and Fixed Preparations of Drosophila Testes
Published on: January 20, 2014
Development and Disease-Dependent Dynamics of Spermatogonial Subpopulations in Human Testicular Tissues
Joana M D Portela1,2, Laura Heckmann1, Joachim Wistuba1
1Center of Reproductive Medicine and Andrology, Institute of Reproductive and Regenerative Biology, Albert-Schweitzer-Campus 1, Building D11, 48149 Münster, Germany.
Abstract:
Cancer therapy and conditioning treatments of non-malignant diseases affect spermatogonial function and may lead to male infertility. Data on the molecular properties of spermatogonia and the influence of disease and/or treatment on spermatogonial subpopulations remain limited. Here, we assessed if the density and percentage of spermatogonial subpopulation changes during development (n = 13) and due to disease and/or treatment (n = 18) in tissues stored in fertility preservation programs, using markers for spermatogonia (MAGEA4), undifferentiated spermatogonia (UTF1), proliferation (PCNA), and global DNA methylation (5mC). Throughout normal prepubertal testicular development, only the density of 5mC-positive spermatogonia significantly increased with age. In comparison, patients affected by disease and/or treatment showed a reduced density of UTF1-, PCNA- and 5mC-positive spermatogonia, whereas the percentage of spermatogonial subpopulations remained unchanged. As an exception, sickle cell disease patients treated with hydroxyurea displayed a reduction in both density and percentage of 5mC- positive spermatogonia. Our results demonstrate that, in general, a reduction in spermatogonial density does not alter the percentages of undifferentiated and proliferating spermatogonia, nor the establishment of global methylation. However, in sickle cell disease patients', establishment of spermatogonial DNA methylation is impaired, which may be of importance for the potential use of this tissues in fertility preservation programs.
Insights
Cancer treatments and diseases can impact male fertility by altering spermatogonia. This study found reduced spermatogonial density in patients, with impaired DNA methylation in sickle cell disease patients, impacting fertility preservation.
Area of Science:
- Reproductive biology
- Male infertility research
- Spermatogonial stem cell biology
Background:
- Cancer therapies and non-malignant disease treatments can impair spermatogonial function, leading to male infertility.
- Limited data exists on molecular properties of spermatogonia and disease/treatment effects on subpopulations.
- Fertility preservation programs store tissues, necessitating understanding of spermatogonial changes.
Purpose of the Study:
- To assess changes in spermatogonial subpopulation density and percentage during development and in disease/treatment contexts.
- To investigate the influence of disease and/or treatment on spermatogonial markers (MAGEA4, UTF1, PCNA) and DNA methylation (5mC).
- To evaluate the implications for fertility preservation strategies.
Main Methods:
- Analysis of testicular tissues from prepubertal development (n=13) and disease/treatment cohorts (n=18) from fertility preservation programs.
- Utilized markers for spermatogonia (MAGEA4), undifferentiated spermatogonia (UTF1), proliferation (PCNA), and global DNA methylation (5mC).
- Quantified density and percentage of spermatogonial subpopulations and correlated with age, disease, and treatment.
Main Results:
- During normal development, only the density of 5mC-positive spermatogonia increased with age.
- Patients with disease/treatment showed reduced density of UTF1-, PCNA-, and 5mC-positive spermatogonia; percentages remained stable.
- Sickle cell disease patients on hydroxyurea had reduced density and percentage of 5mC-positive spermatogonia, indicating impaired DNA methylation establishment.
Conclusions:
- Generally, reduced spermatogonial density does not affect undifferentiated/proliferating cell percentages or global methylation establishment.
- Impaired spermatogonial DNA methylation establishment in sickle cell disease patients is a critical finding.
- These molecular changes have significant implications for the efficacy of fertility preservation for affected individuals.
Related Concept Videos
Spermatogenesis
Spermatogenesis
The process of spermatogenesis can be divided into mitosis, meiosis, and spermiogenesis. During mitosis, the spermatogonia or stem cells divide to produce two identical daughter cells, type A and B spermatogonia. Type-A...
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Development of the Sexual Organs in the Embryo and Fetus
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
The Y Chromosome Determines Maleness
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size....
Testosterone: Functions and Regulation

